Skip to main content

Table 1 Participants’ clinical characteristics and outcomes

From: Peritoneal dialysis catheter salvage performed by nephrologists in tunnel exposure management

PT No

Age

Sex

DS

PDCI method

Months between PDCI and TE

Culture

ESI/TI

Intervention for TE

FU duration after REV (M)

Control of ESI/TI after REV

Outcomes after revision

1

37

F

HTN

Trocar

17

NG

Yes

REV

35

Yes

KT with functioning PDC

2

25

F

GN

Trocar

42

MSSA

Yes

REV

18

Yes

PDC removal d/t recurrent ESI/TI at new tunnel

3

69

M

CGN

Trocar

122

NG

No

REV

31

Yes

Maintenance of PD without problem

4

57

M

DM

Trocar

54

EC

Yes

REV

6

Yes

Patient death with PDC without problem

5

52

F

DM

Trocar

128

NG

No

PDC removal

6

79

M

DM

Surgical

55

MSSA

Yes

REV

3

Yes

Maintenance of PD without problem

7

60

M

HTN

Trocar

98

NG

No

REV

35

Yes

PDC removal d/t recurrent peritonitis

8

43

F

GN

Trocar

48

MRSA

Yes

REV

3

Yes

KT with functioning PDC without problem

9

30

F

GN

Trocar

47

MSSA

Yes

REV

3

No

PDC removal d/t recurrent ESI/TI at TE site

10

51

F

DM

Trocar

16

PS

Yes

REV

1

Yes

Transfer without problem

11

37

M

GN

Trocar

48

PS

Yes

REV

24

No

Re-revision d/t recurrent ESI/TI and PDC removal d/t recurrent ESI/TI despite 2 revisions

12

50

F

HTN

Trocar

27

MSSA

Yes

REV

3

No

PDC removal d/t recurrent TE

  1. Abbreviations: PT No patients number, F female, M male, DS underlying disease of end-stage renal disease, HTN hypertension, GN glomerulonephritis, DM diabetes mellitus, PDCI peritoneal dialysis catheter insertion, TE tunnel extrusion, NG no growth, MSSA methicillin-sensitive Staphylococcus aureus, EC Escherichia coli, MRSA methicillin-resistant Staphylococcus aureus, PS Pseudomonas aeruginosa, ESI/TI exit-site and/or tunnel infection, REV revision, PDC peritoneal dialysis catheter, FU follow-up, KT kidney transplantation, PD peritoneal dialysis, d/t due to